A Study of Avastin (Bevacizumab) in Combination With Low-Dose-Interferon in Patients With Metastatic Clear Cell Renal Cell Carcinoma (RCC).
Clinical trial NCT00796757 · COMPLETED
Trial details
- NCT number
- NCT00796757
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2012-02-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.